Secret bilateral deals rarely stay hidden for long, especially when billions of dollars in medical assistance hang in the balance. A recent joint investigation and analysis by advocacy groups Public Citizen and Partners In Health lays bare a stark reality regarding the White House's foreign policy shift. The Trump administration's newly pursued Memorandums of Understanding (MOUs) under the America First Global Health Strategy are on track to cut U.S. health aid to 18 low-income countries by nearly 60 percent by 2030.
If you look past the bureaucratic language of these agreements, the underlying architecture points to a massive restructuring of international aid. Congress wanted funding levels to remain steady. The administration found a different path through executive power. The consequences will reshape healthcare delivery across the Global South.
Breaking Down the Numbers Behind the Cuts
The numbers are startling. Across the 18 nations targeted by these specific agreements, U.S. government support is set to drop between 43% and 97% compared to historical baselines by the final year of the accord.
Take Rwanda, Liberia, Burundi, Madagascar, and Sierra Leone. These countries face the most severe reductions. Rwanda's funding faces a staggering 97% reduction, while Liberia looks at an 84% slash. These aren't minor budgetary adjustments. They represent an intentional dismantling of long-standing financial pipelines that support local clinics, disease surveillance, and maternal health initiatives.
When you pull back the layers, the cumulative effect amounts to an estimated $2 billion shortfall in global health spending by 2030. This happens even though congressional appropriations bills rejected massive cuts to international health lines, choosing instead to keep spending relatively flat. The executive branch is effectively underspending congressionally allocated budgets through these secretive agreements.
The Trap of Co-Financing Requirements
How does the administration justify these reductions on paper? The answer lies in strict co-financing mandates.
Under the terms of these MOUs, partner governments in Africa must match or make up for the lost American funding through their own domestic budgets. It sounds reasonable in a policy vacuum. In practice, it sets fragile economies up for failure.
Many of these nations operate under immense debt burdens and limited tax bases. They simply don't have extra revenue to absorb millions in sudden healthcare costs. Worse yet, the documents reveal penalty clauses. If these poor countries miss their co-financing targets, they face further financial penalties that accelerate the funding cuts.
For more than half of the 18 countries studied—11 in total—the domestic co-financing commitments fall desperately short of compensating for what the U.S. government is removing. The math doesn't work. Clinics will close. Staff will go unpaid.
The Immediate Public Health Danger
Public health advocates aren't mincing words about what comes next. Preventable deaths will rise.
Programs targeted by these cuts include critical defenses against HIV/AIDS, tuberculosis, and major epidemics. This shift hits at the worst possible time. For instance, the Democratic Republic of Congo and neighboring regions face severe infectious disease outbreaks, including aggressive strains of Ebola and mpox. Weakening regional disease surveillance infrastructure creates vulnerabilities that extend far beyond national borders.
When clinical trials and front-line healthcare delivery lose steady financial backing, pathogens mutate unchecked. I've watched funding shifts disrupt medical supply chains before, and the lag time between a policy change and a localized health crisis is terrifyingly short.
What Happens Next
Transparency remains the primary battleground. Public Citizen filed Freedom of Information Act lawsuits to force the State Department to release the full text of all 34 negotiated MOUs, as only a portion have come to light through legal pressure.
Lawmakers who pushed to keep foreign assistance stable now face an executive branch bypassing legislative intent through bilateral pacts. If you care about global stability or humanitarian outcomes, pay attention to how these funding gaps get filled—or if they get ignored entirely. Expect mounting legal challenges, fierce congressional oversight hearings, and intense pressure on international partners to demand accountability before these agreements lock communities into permanent medical neglect.
